Dr. Daniel S. Kassavin, MD

Dr. Kassavin practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. Kassavin's NPI, 1144428103, was assigned on July 10, 2007. Dr. Kassavin graduated from SUNY Downstate Health Sciences University in 2006. Dr. Kassavin's Ohio license number on file is 35.127258.

Dr. Kassavin's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. Kassavin's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Dr. Kassavin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kassavin practices. Vendor and product names are available with a free account.

Vascular surgery is Dr. Kassavin's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Kassavin is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Kassavin's licenses on file in 4 states: Ohio, Massachusetts, New York and New Jersey.

Dmand AI lists amputation, blood vessel access for dialysis, chronic skin ulcer, heart device and aorta surgery, lymphedema, peripheral vascular disease and varicose veins among the conditions Dr. Kassavin treats.

CMS data shows 213 Medicare services from Dr. Kassavin across 8 procedure codes in 2024, for 141 Medicare patients. Medicare paid $9,283 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. Kassavin in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 64% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kassavin's median patient age at 62, with 55% women.

In 2024, Dr. Kassavin wrote 208 Medicare Part D claims for 59 patients. 83% of them were for generic drugs. CMS names the drug for 181 of them, across 6 drugs with 11 or more claims each, at $18,912 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

Dr. Kassavin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kassavin as offering telehealth. CMS counts 22 procedures of removal of tissue by Dr. Kassavin, more than 70% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Kassavin, published from 2010 to 2016. The most frequent topics are Endovascular Procedures, Prosthesis Design and Stents. Dr. Kassavin has published most often in J Vasc Surg. Dr. Kassavin's most frequent co-authors are George S. Constantinopoulos, MD, Kwame S. Amankwah, MD and Keith Don Calligaro, MD.

CMS Open Payments shows 74 general payments to Dr. Kassavin from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Abbott Laboratories paid the most, $1,664.

Dr. Kassavin graduated from SUNY Downstate Health Sciences University in 2006.

Dr. Kassavin is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.